NinePoint Medical reported a funding round worth $30.7 million as it seeks to expand the commercial footprint for its NvisionVLE imaging system.
The equity round, which began Nov. 12, involved 3 unnamed investors, according to a regulatory filing. Bedford, Mass.-based NinePoint hopes to raise a total of $40.7 million, according to the filing.
NinePoint’s NvisionLVE system is designed to provide high-resolution endoscopic images of organs and tissues. The system can provide cross-sectional, volumetric views of organs, including tissues below the surface, according to the company.
Nearly a year ago, NinePoint tapped Chris von Jako, the former CEO of NeuroTherm, to be its new CEO. Von Jako declined to comment to MassDevice.com about the funding.